Real-World Clinical Practice of Remibrutinib: A 24-Week Prospective, Multicenter, Non-Interventional Study Evaluating the Efficacy and Safety in Adult Patients with Chronic Urticaria Inadequately Controlled by H1 Antihistamines (ChiCTR) - Oct 16, 2026 - P4 | N=200 | Recruiting | Sponsor: Peking Union Medical College Hospital; Peking Union Medical College Hospital
New P4 trial • Dermatology • Immunology • Urticaria
|